Product Information
AMOX-CLAV 200-28.5 MG/5 ML SUS is a generic product labeled by Sandoz Inc., priced at $0.0481 per ML under NDC 00781610246. Its NADAC has been published 523 times since Sep 7, 2016.
FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200; 28.5 mg/5mL; mg/5mL
Manufacturer
Sandoz Inc.NDC
00781610246
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLIN; CLAVULANATE POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065066FDA Approved
6/5/2002
TE Code
AB
On Market Since
6/5/2002
Pharmacological Classes
Price Statistics
The NADAC for AMOX-CLAV 200-28.5 MG/5 ML SUS has been published 523 times since Sep 7, 2016, and over the history we have for it it has declined 44.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0481 per ML |
|---|---|
| All-time high | $0.1023 (Dec 14, 2016) |
| All-time low | $0.0439 (May 22, 2024) |
| 52-week high | $0.0589 |
| 52-week low | $0.0481 |
| Median price | $0.0624 |
| Average price | $0.0635 |
| Largest weekly change | +56.6% (Jul 20, 2022) |
| Weeks tracked | 523 |
| Tracking since | Sep 7, 2016 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin and Clavulanate Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOX-CLAV 200-28.5 MG/5 ML SUS?
The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 200-28.5 MG/5 ML SUS, manufactured by Sandoz Inc., is $0.0481 per ML (NDC 00781610246), effective Sep 30, 2026.
How has the price of AMOX-CLAV 200-28.5 MG/5 ML SUS changed over time?
Over the history we have for it, the NADAC for AMOX-CLAV 200-28.5 MG/5 ML SUS has declined 44.9%. It has been tracked across 523 weekly CMS publications since Sep 7, 2016.
What are the highest and lowest recorded NADAC prices for AMOX-CLAV 200-28.5 MG/5 ML SUS?
Since Sep 7, 2016, the NADAC for AMOX-CLAV 200-28.5 MG/5 ML SUS has ranged from a low of $0.0439 (May 22, 2024) to a high of $0.1023 (Dec 14, 2016), with a median of $0.0624 per ML.
Are there cheaper alternatives to AMOX-CLAV 200-28.5 MG/5 ML SUS?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMOX-CLAV 200-28.5 MG/5 ML SUS in a comparable dosage form, but none are currently priced below it.
Who manufactures AMOX-CLAV 200-28.5 MG/5 ML SUS?
AMOX-CLAV 200-28.5 MG/5 ML SUS (NDC 00781610246) is labeled by Sandoz Inc., and CMS classifies it as a generic product.